Literature DB >> 1518025

Investigation of a female manifesting Becker muscular dystrophy.

I A Glass1, L V Nicholson, E Watkiss, M A Johnson, R G Roberts, S Abbs, S Brittain-Jones, H G Boddie.   

Abstract

Females manifesting Becker muscular dystrophy (BMD) are even more rarely observed than for the allelic condition Duchenne muscular dystrophy. The male proband has typical BMD with greatly raised CK activity and a myopathic muscle biopsy. His mother experienced walking difficulties from 35 years of age and has a myopathy with marked calf hypertrophy, a raised CK, and a myopathic muscle biopsy. Dystrophin analysis was undertaken on both the proband and his mother. Immunoblotting showed a protein of normal size but of reduced abundance in both. Immunocytochemical analysis in the proband indicated that the majority of the fibres showed weak dystrophin labelling and in his mother both dystrophin positive and dystrophin negative fibres were present. Non-random X inactivation at locus DXS255, was observed in DNA isolated from peripheral lymphocytes of the mother. Neither extended multiplex PCR performed on DNA from the proband nor analysis of lymphocyte derived mRNA showed a structural alteration in the dystrophin gene suggesting that an unusual mutation was responsible for BMD in this family.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1518025      PMCID: PMC1016067          DOI: 10.1136/jmg.29.8.578

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  24 in total

1.  MUSCULAR DYSTROPHY (DUCHENNE) IN A GIRL WITH TURNER'S SYNDROME.

Authors:  P FERRIER; F BAMATTER; D KLEIN
Journal:  J Med Genet       Date:  1965-03       Impact factor: 6.318

2.  A study of contractures in muscular dystrophy.

Authors:  K C ARCHIBALD; P J VIGNOS
Journal:  Arch Phys Med Rehabil       Date:  1959-04       Impact factor: 3.966

3.  A convenient multiplex PCR system for the detection of dystrophin gene deletions: a comparative analysis with cDNA hybridisation shows mistypings by both methods.

Authors:  S Abbs; S C Yau; S Clark; C G Mathew; M Bobrow
Journal:  J Med Genet       Date:  1991-05       Impact factor: 6.318

4.  Direct diagnosis of carriers of Duchenne and Becker muscular dystrophy by amplification of lymphocyte RNA.

Authors:  R G Roberts; D R Bentley; T F Barby; E Manners; M Bobrow
Journal:  Lancet       Date:  1990 Dec 22-29       Impact factor: 79.321

5.  Primordial cell pool size and lineage relationships of five human cell types.

Authors:  P J Fialkow
Journal:  Ann Hum Genet       Date:  1973-07       Impact factor: 1.670

6.  Prevalence and incidence of Becker muscular dystrophy.

Authors:  K M Bushby; M Thambyayah; D Gardner-Medwin
Journal:  Lancet       Date:  1991-04-27       Impact factor: 79.321

7.  A homologue of dystrophin is expressed at the neuromuscular junctions of normal individuals and DMD patients, and of normal and mdx mice. Immunological evidence.

Authors:  F Pons; N Augier; J O Léger; A Robert; F M Tomé; M Fardeau; T Voit; L V Nicholson; D Mornet; J J Léger
Journal:  FEBS Lett       Date:  1991-04-22       Impact factor: 4.124

8.  Clinical studies in benign (Becker type) X-linked muscular dystrophy.

Authors:  A E Emery; R Skinner
Journal:  Clin Genet       Date:  1976-10       Impact factor: 4.438

9.  Dystrophin analysis in Duchenne and Becker muscular dystrophy carriers: correlation with intracellular calcium and albumin.

Authors:  L Morandi; M Mora; E Gussoni; S Tedeschi; F Cornelio
Journal:  Ann Neurol       Date:  1990-11       Impact factor: 10.422

10.  Duchenne muscular dystrophy in one of monozygotic twin girls.

Authors:  J Burn; S Povey; Y Boyd; E A Munro; L West; K Harper; D Thomas
Journal:  J Med Genet       Date:  1986-12       Impact factor: 6.318

View more
  5 in total

1.  X-chromosome methylation ratios as indicators of chromosomal activity: evidence of intraindividual divergencies among tissues of different embryonal origin.

Authors:  J Azofeifa; R Waldherr; M Cremer
Journal:  Hum Genet       Date:  1996-03       Impact factor: 4.132

2.  Skewed inactivation of an X chromosome deleted at the dystrophin gene in an asymptomatic mother and her affected daughter.

Authors:  F Tihy; N Vogt; D Recan; B Malfoy; F Leturcq; M Coquet; F Serville; D Fontan; J M Guillard; J C Kaplan
Journal:  Hum Genet       Date:  1994-05       Impact factor: 4.132

3.  X inactivation patterns in female monozygotic twins and their families.

Authors:  E Watkiss; T Webb; G Rysiecki; N Girdler; E Hewett; S Bundey
Journal:  J Med Genet       Date:  1994-10       Impact factor: 6.318

4.  Integrated study of 100 patients with Xp21 linked muscular dystrophy using clinical, genetic, immunochemical, and histopathological data. Part 3. Differential diagnosis and prognosis.

Authors:  L V Nicholson; M A Johnson; K M Bushby; D Gardner-Medwin; A Curtis; I B Ginjaar; J T den Dunnen; J L Welch; T J Butler; E Bakker
Journal:  J Med Genet       Date:  1993-09       Impact factor: 6.318

5.  X-chromosome methylation in manifesting and healthy carriers of dystrophinopathies: concordance of activation ratios among first degree female relatives and skewed inactivation as cause of the affected phenotypes.

Authors:  J Azofeifa; T Voit; C Hübner; M Cremer
Journal:  Hum Genet       Date:  1995-08       Impact factor: 4.132

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.